---
title: Callaghan MU, Negrier C, Paz-Priel I, etÂ al. Long-term outcomes with emicizumab
  prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4
  studies. Blood. 2021;137(16):2231-2242
date: '2023-10-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37824158/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231012180716&v=2.17.9.post6+86293ac
source: Blood
description: No ...
disable_comments: true
---
No ...